Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Adaptilens logo — The first biomimetic accommodating IOL

Adaptilens

The first biomimetic accommodating IOL

Founded 2019 United States Newton, United States 9 employees Series A Total: $19.10M Health Care, Medical Devices

General Information

Company Name Adaptilens
Founded Year 2019
Location United States Newton, United States
Employees 9
Industries Health Care, Medical Devices
Funding Stage Series A
Business Model B2B, B2B2C
Revenue Model Product Sales, One Time Purchase, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with Adaptilens. To contact Adaptilens, visit adaptilens.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Adaptilens compare?

A PDF of Adaptilens and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Adaptilens soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Adaptilens

Adaptilens, founded in 2019 and headquartered in the United States, operates at the intersection of the Health Care and Medical Devices industries. The company is pioneering a transformative approach to vision correction with its flagship product, the Adaptilens accommodating intraocular lens (A-IOL).

With its slogan, "The first biomimetic accommodating IOL," Adaptilens aims to restore youthful vision by imitating the natural lens of a healthy young eye. The A-IOL mimics the eye’s natural accommodation response, allowing users to see clearly at various distances without glasses.

In April 2024, Adaptilens successfully secured a $17.50M Series A investment from notable investors including Pillar, Perceptive Advisors, 380 Cap, and Accanto Partners. This significant investment underscores confidence in Adaptilens' innovative potential in addressing a critical need in eye care technology.

Business keywords: ophthalmology, cataract surgery, IOL technology, vision correction, eye care innovation, innovative polymers, lens technology, vision enhancement, eye surgery, medical device innovation

Services & Products

development of accommodating intraocular lenses
vision correction solutions
restoration of youthful vision

Target Customers

cataract patients ophthalmologists refractive and cataract surgeons senior citizens experiencing vision loss

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $17.50M 4
Pillar Perceptive Advisors 380 Cap
Pillar, Perceptive Advisors +2
01 Apr 2024
Seed $1.60M 2
Pillar Accanto Partners
Pillar, Accanto Partners
01 Nov 2020

Adaptilens Alternatives & Competitors

Adaptilens vs
Atia Vision
Atia Vision United States

Atia Vision is a portfolio company of Shifamed, LLC, a highly-specialized medical innovation hub foc...

Venture round
34 employees
Biotechnology, Health Care
Compare Adaptilens vs Atia Vision
Adaptilens vs
LENTECHS
LENTECHS United States

Developing a new generation of soft, suspended contact lens

Venture round
9 employees
Biotechnology, Health Care
Adaptilens vs
EYE PCR BV
EYE PCR BV The Netherlands

Our mission: bring extraordinary science to life-changing therapies for patients with eye disorders

9 employees
Health Care, Medical Devices

FAQ About Adaptilens

The first biomimetic accommodating IOL
Adaptilens was founded in 2019.
Adaptilens is headquartered in Newton, United States.
Adaptilens operates in Health Care and Medical Devices. Its work centres on ophthalmology, cataract surgery, IOL technology and vision correction. Its customers include cataract patients, ophthalmologists and refractive and cataract surgeons.
Adaptilens has a B2B and B2B2C business model. Its revenue comes from Product Sales, One Time Purchase and Tiered Pricing.
Adaptilens has approximately 9 employees.
Adaptilens has completed 2 funding rounds, raising a total of $19.10M. The latest funding stage is Series A.
Adaptilens offers: development of accommodating intraocular lenses, vision correction solutions, restoration of youthful vision.
Top alternatives and competitors to Adaptilens include Atia Vision, LENTECHS, EYE PCR BV, AcuFocus, HOYA SURGICAL OPTICS GMBH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Adaptilens and Atia Vision are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Adaptilens, https://bouncewatch.com/company/adaptilens, updated 23 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes